Literature DB >> 35000151

The E3 Ubiquitin Ligase TRAF6 Interacts with the Cellular Prion Protein and Modulates Its Solubility and Recruitment to Cytoplasmic p62/SQSTM1-Positive Aggresome-Like Structures.

Lara Masperone1, Marta Codrich1, Francesca Persichetti2, Stefano Gustincich1,3, Silvia Zucchelli1,2, Giuseppe Legname4.   

Abstract

The cellular prion protein (PrPC) is a ubiquitous glycoprotein highly expressed in the brain where it is involved in neurite outgrowth, copper homeostasis, NMDA receptor regulation, cell adhesion, and cell signaling. Conformational conversion of PrPC into its insoluble and aggregation-prone scrapie form (PrPSc) is the trigger for several rare devastating neurodegenerative disorders, collectively referred to as prion diseases. Recent work indicates that the ubiquitin-proteasome system is involved in quality control of PrPC. To better dissect the role of ubiquitination in PrPC physiology, we focused on the E3 RING ubiquitin ligase tumor necrosis factor receptor (TNFR)-associated factor 6 (TRAF6). Here, we report that PrPC interacts with TRAF6 both in vitro, in cells, and in vivo, in the mouse brain. Transient overexpression of TRAF6 indirectly modulates PrPC ubiquitination and triggers redistribution of PrPC into the insoluble fraction. Importantly, in the presence of wild-type TRAF6, but not a mutant lacking E3 ligase activity, PrPC accumulates into cytoplasmic aggresome-like inclusions containing TRAF6 and p62/SQSTM1. Our results suggest that TRAF6 ligase activity could exert a role in the regulation of PrPC redistribution in cells under physiological conditions. This novel interaction may uncover possible mechanisms of cell clearance/reorganization in prion diseases.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Aggresomes; Cellular prion protein; TRAF6; Ubiquitination

Mesh:

Substances:

Year:  2022        PMID: 35000151     DOI: 10.1007/s12035-021-02666-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  53 in total

1.  Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein.

Authors:  Y Yedidia; L Horonchik; S Tzaban; A Yanai; A Taraboulos
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

2.  Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1α/GP78 axis.

Authors:  J H Lee; Y-S Han; Y M Yoon; C W Yun; S P Yun; S M Kim; H Y Kwon; D Jeong; M J Baek; H J Lee; S-J Lee; H J Han; S H Lee
Journal:  Oncogene       Date:  2017-07-31       Impact factor: 9.867

3.  Lysosomes as key organelles in the pathogenesis of prion encephalopathies.

Authors:  L Laszlo; J Lowe; T Self; N Kenward; M Landon; T McBride; C Farquhar; I McConnell; J Brown; J Hope
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

4.  Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice.

Authors:  Shin-Chung Kang; David R Brown; Matthew Whiteman; Ruliang Li; Tao Pan; George Perry; Thomas Wisniewski; Man-Sun Sy; Boon-Seng Wong
Journal:  J Pathol       Date:  2004-05       Impact factor: 7.996

5.  Identification of novel putative-binding proteins for cellular prion protein and a specific interaction with the STIP1 homology and U-Box-containing protein 1.

Authors:  Ana Paula Lappas Gimenez; Larissa Morato Luciani Richter; Mariana Campos Atherino; Breno Castello Branco Beirão; Celso Fávaro; Michele Dietrich Moura Costa; Silvio Marques Zanata; Bettina Malnic; Adriana Frohlich Mercadante
Journal:  Prion       Date:  2015-08-03       Impact factor: 3.931

6.  Creutzfeldt-Jakob disease prion proteins in human brains.

Authors:  J M Bockman; D T Kingsbury; M P McKinley; P E Bendheim; S B Prusiner
Journal:  N Engl J Med       Date:  1985-01-10       Impact factor: 91.245

7.  Disease-associated prion protein oligomers inhibit the 26S proteasome.

Authors:  Mark Kristiansen; Pelagia Deriziotis; Derek E Dimcheff; Graham S Jackson; Huib Ovaa; Heike Naumann; Anthony R Clarke; Fijs W B van Leeuwen; Victoria Menéndez-Benito; Nico P Dantuma; John L Portis; John Collinge; Sarah J Tabrizi
Journal:  Mol Cell       Date:  2007-04-27       Impact factor: 17.970

8.  Ubiquitin-specific protease 14 modulates degradation of cellular prion protein.

Authors:  Takujiro Homma; Daisuke Ishibashi; Takehiro Nakagaki; Takayuki Fuse; Tsuyoshi Mori; Katsuya Satoh; Ryuichiro Atarashi; Noriyuki Nishida
Journal:  Sci Rep       Date:  2015-06-10       Impact factor: 4.379

9.  Ubiquitin ligase gp78 targets unglycosylated prion protein PrP for ubiquitylation and degradation.

Authors:  Jia Shao; Vitnary Choe; Haili Cheng; Yien Che Tsai; Allan M Weissman; Shiwen Luo; Hai Rao
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

10.  Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system.

Authors:  Chris McKinnon; Rob Goold; Ralph Andre; Anny Devoy; Zaira Ortega; Julie Moonga; Jacqueline M Linehan; Sebastian Brandner; José J Lucas; John Collinge; Sarah J Tabrizi
Journal:  Acta Neuropathol       Date:  2015-12-08       Impact factor: 17.088

View more
  1 in total

Review 1.  Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets.

Authors:  Stefano Thellung; Alessandro Corsaro; Irene Dellacasagrande; Mario Nizzari; Martina Zambito; Tullio Florio
Journal:  Front Neurosci       Date:  2022-09-06       Impact factor: 5.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.